508 Results

People

  1. Norton
    Norton
  2. Hudis
    Hudis
  3. Robson
    Robson
  4. Seidman
    Seidman
  5. Offit
    Offit
  6. Gilewski
    Gilewski
  7. Dang
    Dang
  8. Solit
    Solit
  9. Rosen
    Rosen
  10. Berger
    Berger

Groups

  1. Breast Medicine Service (508)
  2. Department of Medicine (508)
  3. Solid Tumor Oncology Division (508)
  4. Survivorship Research (305)
  5. Population Sciences Research Program (171)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (166)
  7. GSK Faculty (138)
  8. Epidemiology and Biostatistics (113)
  9. Surgery (87)
  10. Biostatistics Service (72)
  1. "female"
  2. "Breast Medicine Service"
Formats
  1. Journal Article (462)
  2. Conference Paper (14)
  3. Review (9)
  4. Meeting Abstract (5)
  5. Miscellaneous (5)
  6. Editorial (4)
  7. Research Letter (4)
  8. Guidelines (3)
  9. Correspondence (2)
Groups
  1. Breast Medicine Service (508)
  2. Department of Medicine (508)
  3. Solid Tumor Oncology Division (508)
  4. Survivorship Research (305)
  5. Population Sciences Research Program (171)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (166)

More Groups

People
  1. Larry Norton (138)
  2. Clifford Hudis (109)
  3. Mark Robson (100)
  4. Andrew Seidman (71)
  5. Kenneth Offit (57)
  6. Teresa Gilewski (37)

More People

Years
  1. 2024 (18)
  2. 2023 (48)
  3. 2022 (49)
  4. 2021 (23)
  5. 2020 (17)
  6. 2019 (21)

More Years

Publications
  1. Journal of Clinical Oncology (51)
  2. Breast Cancer Research and Treatment (26)
  3. Cancer (23)
  4. Clinical Cancer Research (18)
  5. Seminars in Oncology (18)
  6. Annals of Surgical Oncology (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (63)
  2. Elsevier Inc. (56)
  3. Springer (55)
  4. Nature Publishing Group (51)
  5. Oxford University Press (42)
  6. American Association for Cancer Research (34)

More Publishers

Results (508)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of patients with advanced-stage HER2-positive breast cancer: Current evidence and future perspectives
    Review

    Marra, A.; Chandarlapaty, S.; Modi, S.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α
    Journal Article

    Ren, Z.; Dharmaratne, M.; Liang, H.; Benard, O.; Morales-Gallego, M.; Suyama, K.; Kumar, V.; Fard, A. T.; Kulkarni, A. S.; Prystowsky, M.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: Updated survival results from a phase II trial (DESTINY-Breast01)
    Journal Article

    Saura, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; Iwata, H.; Tsurutani, J.; Sohn, J.; Mathias, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Mechanisms of exercise intolerance across the breast cancer continuum: A pooled analysis of individual patient data
    Journal Article

    Scott, J. M.; Lee, J.; Michalski, M. G.; Batch, K.; Simpson, A. L.; Peoples, J.; Lee, C. P.; Harrison, J. N.; Yu, A. F.; Sasso, J. P.; more...
    Medicine and Science in Sports and Exercise (2024)

    Fulltext@MSK | Save
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer
    Journal Article

    Bardia, A.; Jhaveri, K.; Kalinsky, K.; Pernas, S.; Tsurutani, J.; Xu, B.; Hamilton, E.; Im, S. A.; Nowecki, Z.; Sohn, J.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline
    Journal Article

    Bedrosian, I.; Somerfield, M. R.; Achatz, M. I.; Boughey, J. C.; Curigliano, G.; Friedman, S.; Kohlmann, W. K.; Kurian, A. W.; Laronga, C.; Lynce, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase Ia/b study of giredestrant ± palbociclib and ± luteinizing hormone-releasing hormone agonists in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; Bellet, M.; Turner, N. C.; Loi, S.; Bardia, A.; Boni, V.; Sohn, J.; Neilan, T. G.; Villanueva-Vázquez, R.; Kabos, P.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1-mutant breast cancer
    Journal Article

    Kingston, B.; Pearson, A.; Herrera-Abreu, M. T.; Sim, L. X.; Cutts, R. J.; Shah, H.; Moretti, L.; Kilburn, L. S.; Johnson, H.; Macpherson, I. R.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save